Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 950

1.

New targets for overactive bladder-ICI-RS 2109.

Fry CH, Chakrabarty B, Hashitani H, Andersson KE, McCloskey K, Jabr RI, Drake MJ.

Neurourol Urodyn. 2019 Nov 18. doi: 10.1002/nau.24228. [Epub ahead of print] Review.

PMID:
31737931
2.

Hematology and plasma biochemistries in the Blanding's turtle (Emydoidea blandingii) in Lake County, Illinois.

Mumm LE, Winter JM, Andersson KE, Glowacki GA, Adamovicz LA, Allender MC.

PLoS One. 2019 Nov 15;14(11):e0225130. doi: 10.1371/journal.pone.0225130. eCollection 2019.

3.

Urine composition in pigs is regulated in both the ureter and the bladder.

Jakobsen LK, Andersson KE, Norregaard R, Olsen LH.

Physiol Res. 2019 Oct 25;68(5):785-792. Epub 2019 Aug 19.

4.

Agents in early development for treatment of bladder dysfunction - promise of drugs acting at TRP channels?

Andersson KE.

Expert Opin Investig Drugs. 2019 Sep;28(9):749-755. doi: 10.1080/13543784.2019.1654994. Epub 2019 Aug 14. Review.

PMID:
31399015
5.

TRP Channels as Lower Urinary Tract Sensory Targets.

Andersson KE.

Med Sci (Basel). 2019 May 22;7(5). pii: E67. doi: 10.3390/medsci7050067. Review.

6.

Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects.

Andersson KE, Longstreth J, Brucker BM, Campeau L, Cheng L, Francis L, Fein S.

Pharm Res. 2019 Apr 29;36(6):92. doi: 10.1007/s11095-019-2628-1.

7.

Oxidative stress and lower urinary tract symptoms: cause or consequence?

Andersson KE.

BJU Int. 2019 May;123(5):749-750. doi: 10.1111/bju.14633. No abstract available.

PMID:
31008563
8.

Streptozotocin-induced diabetes causes upregulation of serotonin (5-HT)2A/C receptors in lumbosacral cord motoneurons and down regulation of serotonergic paraneurons in the urethra.

Cao N, Huang J, Ni J, Si J, Gu B, Wang Z, Andersson KE.

Brain Res. 2019 Jul 15;1715:21-26. doi: 10.1016/j.brainres.2019.03.009. Epub 2019 Mar 14.

PMID:
30880116
9.

New concepts in regenerative medicine approaches to the treatment of female stress urinary incontinence.

Bennington J, Williams JK, Andersson KE.

Curr Opin Urol. 2019 Jul;29(4):380-384. doi: 10.1097/MOU.0000000000000617.

PMID:
30855380
10.

Liquid chromatography-mass spectrometry identification of serum biomarkers for nocturia in aged men.

Kira S, Mitsui T, Miyamoto T, Ihara T, Nakagomi H, Hashimoto Y, Takamatsu H, Tanahashi M, Takeda M, Sawada N, Andersson KE, Takeda M.

World J Urol. 2019 Oct;37(10):2199-2205. doi: 10.1007/s00345-019-02647-4. Epub 2019 Jan 23.

PMID:
30673830
11.

Cell Versus Chemokine Therapy Effects on Cell Mobilization to Chronically Dysfunctional Urinary Sphincters of Nonhuman Primates.

Williams JK, Mariya S, Suparto I, Lankford SS, Andersson KE.

Int Neurourol J. 2018 Dec;22(4):260-267. doi: 10.5213/inj.1836126.063. Epub 2018 Dec 31.

12.

Intraprostatic injections for lower urinary tract symptoms/benign prostatic enlargement treatment.

Lombardo R, Andersson KE, Tubaro A, De Nunzio C.

Minerva Urol Nefrol. 2018 Dec;70(6):570-578. doi: 10.23736/S0393-2249.18.03233-2. Epub 2018 Oct 3.

13.

Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract Symptoms.

Serati M, Andersson KE, Dmochowski R, Agrò EF, Heesakkers J, Iacovelli V, Novara G, Khullar V, Chapple C.

Eur Urol. 2019 Jan;75(1):129-168. doi: 10.1016/j.eururo.2018.09.029. Epub 2018 Oct 4.

PMID:
30293906
14.

Nonhuman primate model of persistent erectile and urinary dysfunction following radical prostatectomy: Feasibility of minimally invasive therapy.

Zambon JP, Patel M, Hemal A, Badlani G, Andersson KE, Magalhaes RS, Lankford S, Dean A, Williams JK.

Neurourol Urodyn. 2018 Sep;37(7):2141-2150. doi: 10.1002/nau.23536. Epub 2018 Aug 31.

PMID:
30168617
15.

Which molecular targets do we need to focus on to improve lower urinary tract dysfunction? ICI-RS 2017.

Andersson KE, Fry C, Panicker J, Rademakers K.

Neurourol Urodyn. 2018 Jun;37(S4):S117-S126. doi: 10.1002/nau.23516. Review.

PMID:
30133792
16.

Fibrosis and the bladder, implications for function ICI-RS 2017.

Fry CH, Kitney DG, Paniker J, Drake MJ, Kanai A, Andersson KE.

Neurourol Urodyn. 2018 Jun;37(S4):S7-S12. doi: 10.1002/nau.23725. Review.

PMID:
30133788
17.

6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE.

Abrams P, Andersson KE, Apostolidis A, Birder L, Bliss D, Brubaker L, Cardozo L, Castro-Diaz D, O'Connell PR, Cottenden A, Cotterill N, de Ridder D, Dmochowski R, Dumoulin C, Fader M, Fry C, Goldman H, Hanno P, Homma Y, Khullar V, Maher C, Milsom I, Newman D, Nijman RJM, Rademakers K, Robinson D, Rosier P, Rovner E, Salvatore S, Takeda M, Wagg A, Wagner T, Wein A; members of the committees.

Neurourol Urodyn. 2018 Sep;37(7):2271-2272. doi: 10.1002/nau.23551. Epub 2018 Aug 14. No abstract available.

PMID:
30106223
18.

Extended periprostatic nerve distributions on the prostate surface confirmed using diffusion tensor imaging.

Sievert KD, Hennenlotter J, Dillenburg T, Toomey P, Wöllner J, Zweers P, Pannek J, Andersson KE, Amend B.

BJU Int. 2019 Jun;123(6):995-1004. doi: 10.1111/bju.14508. Epub 2019 Jan 29.

PMID:
30091828
19.

The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy.

Andersson KE, Choudhury N, Cornu JN, Huang M, Korstanje C, Siddiqui E, Van Kerrebroeck P.

Ther Adv Urol. 2018 Jul 6;10(8):243-256. doi: 10.1177/1756287218781255. eCollection 2018 Aug. Review.

20.

Neuroepithelial control of mucosal inflammation in acute cystitis.

Butler DSC, Ambite I, Nagy K, Cafaro C, Ahmed A, Nadeem A, Filenko N, Tran TH, Andersson KE, Wullt B, Puthia M, Svanborg C.

Sci Rep. 2018 Jul 20;8(1):11015. doi: 10.1038/s41598-018-28634-0.

21.

Increased autophagy contributes to impaired smooth muscle function in neurogenic lower urinary tract dysfunction.

Eberli D, Horst M, Mortezavi A, Andersson KE, Gobet R, Sulser T, Simon HU, Salemi S.

Neurourol Urodyn. 2018 Nov;37(8):2414-2424. doi: 10.1002/nau.23705. Epub 2018 May 24.

PMID:
29797356
22.

The serotonin (5-hydroxytryptamine) 5-HT7 receptor is up-regulated in Onuf's nucleus in rats with chronic spinal cord injury.

Ni J, Cao N, Wang X, Zhan C, Si J, Gu B, Andersson KE.

BJU Int. 2019 Apr;123(4):718-725. doi: 10.1111/bju.14405. Epub 2018 Jun 15.

PMID:
29781566
23.

PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery.

Andersson KE.

Br J Pharmacol. 2018 Jul;175(13):2554-2565. doi: 10.1111/bph.14205. Epub 2018 Apr 25. Review.

24.

Current concepts of the acontractile bladder.

Colaco M, Osman NI, Karakeçi A, Artibani W, Andersson KE, Badlani GH.

BJU Int. 2018 Aug;122(2):195-202. doi: 10.1111/bju.14236. Epub 2018 May 3. Review.

25.

Pharmacotherapy for Nocturia.

Andersson KE, Van Kerrebroeck P.

Curr Urol Rep. 2018 Feb 9;19(1):8. doi: 10.1007/s11934-018-0750-y. Review.

26.

Animal Modelling of Interstitial Cystitis/Bladder Pain Syndrome.

Birder L, Andersson KE.

Int Neurourol J. 2018 Jan;22(Suppl 1):S3-9. doi: 10.5213/inj.1835062.531. Epub 2018 Jan 31. Review.

27.

Aquaporin expression in the fetal porcine urinary tract changes during gestation.

Jakobsen LK, Trelborg KF, Kingo PS, Hoyer S, Andersson KE, Djurhuus JC, Norregaard R, Olsen LH.

Physiol Res. 2018 May 4;67(2):283-292. Epub 2018 Jan 5.

28.

Neuropelveology: An Emerging Discipline for the Management of Chronic Pelvic Pain.

Possover M, Andersson KE, Forman A.

Int Neurourol J. 2017 Dec;21(4):243-246. doi: 10.5213/inj.1735036.518. Epub 2017 Dec 31. Review.

29.

Current Pharmacologic Approaches in Painful Bladder Research: An Update.

Andersson KE, Birder L.

Int Neurourol J. 2017 Dec;21(4):235-242. doi: 10.5213/inj.1735022.511. Epub 2017 Dec 31. Review.

30.

Erectile Dysfunction and Lower Urinary Tract Symptoms.

De Nunzio C, Roehrborn CG, Andersson KE, McVary KT.

Eur Urol Focus. 2017 Oct;3(4-5):352-363. doi: 10.1016/j.euf.2017.11.004. Epub 2017 Nov 27. Review.

PMID:
29191671
31.

Urethral afferent signalling: role of 5-HT paraneurons.

Andersson KE.

Acta Physiol (Oxf). 2018 Feb;222(2). doi: 10.1111/apha.12993. Epub 2017 Nov 28. No abstract available.

PMID:
29121450
32.

Oxidative stress and its possible relation to lower urinary tract functional pathology.

Andersson KE.

BJU Int. 2018 Apr;121(4):527-533. doi: 10.1111/bju.14063. Epub 2017 Nov 9. Review.

33.

Development of contractile properties in the fetal porcine urinary bladder.

Jakobsen LK, Trelborg KF, Simonsen U, Andersson KE, Olsen LH.

Pediatr Res. 2018 Jan;83(1-1):148-155. doi: 10.1038/pr.2017.181. Epub 2017 Oct 4.

PMID:
28976496
34.

Characteristics of the mechanosensitive bladder afferent activities in relation with microcontractions in male rats with bladder outlet obstruction.

Aizawa N, Ichihara K, Fukuhara H, Fujimura T, Andersson KE, Homma Y, Igawa Y.

Sci Rep. 2017 Aug 9;7(1):7646. doi: 10.1038/s41598-017-07898-y.

35.

Drugs for the overactive bladder: are there differences in persistence and compliance?

Andersson KE.

Transl Androl Urol. 2017 Jun;6(3):597-601. doi: 10.21037/tau.2017.03.90. No abstract available.

36.

Efficacy and Initial Safety Profile of CXCL12 Treatment in a Rodent Model of Urinary Sphincter Deficiency.

Koudy Williams J, Dean A, Lankford S, Andersson KE.

Stem Cells Transl Med. 2017 Aug;6(8):1740-1746. doi: 10.1002/sctm.16-0497. Epub 2017 Jul 17.

37.

Chronic spinal cord injury causes upregulation of serotonin (5-HT)2A and 5-HT2C receptors in lumbosacral cord motoneurons.

Cao N, Ni J, Wang X, Tu H, Gu B, Si J, Wu G, Andersson KE.

BJU Int. 2018 Jan;121(1):145-154. doi: 10.1111/bju.13964. Epub 2017 Aug 18.

38.

Pharmacology: Cardiovascular effects of mirabegron.

Andersson KE.

Nat Rev Urol. 2017 Oct;14(10):587-588. doi: 10.1038/nrurol.2017.113. Epub 2017 Jul 11. No abstract available.

PMID:
28695920
39.

Re: Inhibition of Cholinergic Neurotransmission by β3-adrenoceptors Depends on Adenosine Release and A1 Receptors Activation in Human and Rat Urinary Bladders.

Andersson KE.

Eur Urol. 2017 Oct;72(4):650-651. doi: 10.1016/j.eururo.2017.05.046. Epub 2017 Jun 7. No abstract available.

PMID:
28601353
40.

Toll-like receptor 7 is overexpressed in the bladder of Hunner-type interstitial cystitis, and its activation in the mouse bladder can induce cystitis and bladder pain.

Ichihara K, Aizawa N, Akiyama Y, Kamei J, Masumori N, Andersson KE, Homma Y, Igawa Y.

Pain. 2017 Aug;158(8):1538-1545. doi: 10.1097/j.pain.0000000000000947.

PMID:
28595240
41.

Evaluating the Procedure for Performing Awake Cystometry in a Mouse Model.

Mann-Gow TK, Larson TR, Wøien CT, Andersen TM, Andersson KE, Zvara P.

J Vis Exp. 2017 May 20;(123). doi: 10.3791/55588.

42.

Characterization of a Murine Model of Bioequivalent Bladder Wound Healing and Repair Following Subtotal Cystectomy.

Zarifpour M, Andersson KE, Kelkar SS, Mohs A, Mendelsohn C, Schneider K, Marini F, Christ GJ.

Biores Open Access. 2017 May 1;6(1):35-45. doi: 10.1089/biores.2017.0011. eCollection 2017.

43.

Can we define and characterize the aging lower urinary tract?-ICI-RS 2015.

Vahabi B, Wagg AS, Rosier PFWM, Rademakers KLJ, Denys MA, Pontari M, Lovick T, Valentini FA, Nelson PP, Andersson KE, Fry CH.

Neurourol Urodyn. 2017 Apr;36(4):854-858. doi: 10.1002/nau.23035. Review.

44.

On the Site and Mechanism of Action of β3-Adrenoceptor Agonists in the Bladder.

Andersson KE.

Int Neurourol J. 2017 Mar 24;21(1):6-11. doi: 10.5213/inj.1734850.425. Review.

45.

Can incontinence be cured? A systematic review of cure rates.

Riemsma R, Hagen S, Kirschner-Hermanns R, Norton C, Wijk H, Andersson KE, Chapple C, Spinks J, Wagg A, Hutt E, Misso K, Deshpande S, Kleijnen J, Milsom I.

BMC Med. 2017 Mar 24;15(1):63. doi: 10.1186/s12916-017-0828-2. Review.

46.

Electrospun biodegradable microfibers induce new collagen formation in a rat abdominal wall defect model: A possible treatment for pelvic floor repair?

Glindtvad C, Chen M, Vinge Nygaard J, Wogensen L, Forman A, Danielsen CC, Taskin MB, Andersson KE, Axelsen SM.

J Biomed Mater Res B Appl Biomater. 2018 Feb;106(2):680-688. doi: 10.1002/jbm.b.33875. Epub 2017 Mar 17.

PMID:
28306194
47.

Association of lower urinary tract syndrome with peripheral arterial occlusive disease.

Lin WY, Andersson KE, Lin CL, Kao CH, Wu HC.

PLoS One. 2017 Mar 16;12(3):e0170288. doi: 10.1371/journal.pone.0170288. eCollection 2017.

48.

Regenerative pharmacology in urology.

Andersson KE, Williams JK.

Investig Clin Urol. 2017 Mar;58(2):79-81. doi: 10.4111/icu.2017.58.2.79. Epub 2017 Feb 7. No abstract available.

49.

Wholegrain oat diet changes the expression of genes associated with intestinal bile acid transport.

Andersson KE, Chawade A, Thuresson N, Rascon A, Öste R, Sterner O, Olsson O, Hellstrand P.

Mol Nutr Food Res. 2017 Jul;61(7). doi: 10.1002/mnfr.201600874. Epub 2017 Mar 30.

PMID:
28205325
50.

Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome.

Walker SJ, Zambon J, Andersson KE, Langefeld CD, Matthews CA, Badlani G, Bowman H, Evans RJ.

J Urol. 2017 Aug;198(2):369-375. doi: 10.1016/j.juro.2017.02.022. Epub 2017 Feb 12.

PMID:
28202356

Supplemental Content

Loading ...
Support Center